MedKoo Cat#: 341087 | Name: Y 25510

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Y 25510 is a biochemical.

Chemical Structure

Y 25510
Y 25510
CAS#145194-32-7

Theoretical Analysis

MedKoo Cat#: 341087

Name: Y 25510

CAS#: 145194-32-7

Chemical Formula: C19H22N4O3

Exact Mass: 354.1692

Molecular Weight: 354.41

Elemental Analysis: C, 64.39; H, 6.26; N, 15.81; O, 13.54

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Y 25510; Y-25510; Y25510.
IUPAC/Chemical Name
1H-Pyrazolo(3,4-b)pyridine-1-acetic acid, 3-(4-(2-(dimethylamino)-1-methylethoxy)phenyl)-, (+-)-
InChi Key
DYLPVOLNSXUKPG-UHFFFAOYSA-N
InChi Code
InChI=1S/C19H22N4O3/c1-13(11-22(2)3)26-15-8-6-14(7-9-15)18-16-5-4-10-20-19(16)23(21-18)12-17(24)25/h4-10,13H,11-12H2,1-3H3,(H,24,25)
SMILES Code
CC(CN(C)C)Oc1ccc(cc1)c2c3cccnc3n(n2)CC(=O)O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 354.41 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Azuma J, Ogura M, Yamamoto I, Hisadome M, Fukuda T, Ikeda Y, Mori H, Oka T, Asano S. The effect of Y-25510 injection on the serum levels of some cytokines in healthy adult volunteers. Eur J Clin Pharmacol. 1998 Feb;53(6):411-9. PubMed PMID: 9551699. 2: Kusuhara H, Komatsu H, Hisadome M, Ikeda Y. (+/-)-3-[4-(2-dimethylamino-1-methylethoxy)-phenyl]-1H-pyrazolo[3,4- B]pyridine-1-acetic acid (Y-25510) stimulates production of IL-1 beta and IL-6 at the level of messenger RNA expression in cultured human monocytes. Int J Immunopharmacol. 1996 Dec;18(12):719-28. PubMed PMID: 9172015. 3: Hisadome M, Fukuda T, Matsuyuki H, Ikeda Y, Nomoto K. Enhancement of in vivo production of IL-1 alpha and IL-6 in mice by Y-25510, a 1H-pyrazolo[3,4-b]pyridine-1 acetic acid derivative. Int J Immunopharmacol. 1996 Jun-Jul;18(6-7):379-84. PubMed PMID: 9024939. 4: Hisadome M, Fukuda T, Terasawa M, Oe T, Takahata H, Goto K, Tsuru S, Nomoto K. Enhancement of host defense by Y-25510, (+-)-3-[4-(2-dimethylamino-1-methylethoxy)phenyl]-1H-pyrazolo[3,4 -b] pyridine-1-acetic acid, a novel synthetic compound. A comparison with recombinant human granulocyte colony-stimulating factor in 5-fluorouracil-treated mice. Int J Immunopharmacol. 1992 Oct;14(7):1195-201. PubMed PMID: 1280628.